Compounds of the formula (I):
or pharmaceutically acceptable salts thereof, wherein R
1
and R
2
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).
化合物的公式(I):或其药学上可接受的盐,其中R1和R2如本文所定义。还揭示了制备这些化合物的方法,并将这些化合物用于治疗与
钙释放激活
钙通道(CRAC)相关的疾病。